Abstract
We report a case of an immunocompromised patient affected by chronic hepatitis B virus (HBV) with high basal HBV viremia (>8 log 10 IU/ml) who failed an entecavir regimen, despite the absence of primary or secondary drug resistance mutations. The patient achieved sustained virological success (serum HBV DNA
Original language | English |
---|---|
Pages (from-to) | 367-370 |
Number of pages | 4 |
Journal | Infection |
Volume | 39 |
Issue number | 4 |
DOIs | |
Publication status | Published - Aug 2011 |
Keywords
- Drug resistance
- Entecavir
- Hepatitis B
- Immunocompromised
- Therapy
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases